Plaintiff Files Pradaxa Injury Lawsuit After Suffering Internal Bleeding

Plaintiff Files Pradaxa Injury Lawsuit After Suffering Internal Bleeding

By Andrea Gressman

A Plaintiff looking to treat his non-valvular atrial fibrillation must undergo life-long monitoring and treatment due to excessive internal bleeding side effects he endured from Pradaxa use, according to a Pradaxa lawsuit filed against pharmaceutical company, Boehringer Ingelheim, on July 18, 2012. The Pradaxa lawsuit was filed in the U.S. District Court, Southern District of Illinois.

The Plaintiff alleges in the Pradaxa injury lawsuit that Boehringer Ingelheim should be held liable for its role in the Plaintiff’s internal bleeding injuries because it failed to give adequate warnings to both patients and doctors that Pradaxa could cause excessive bleeding without a known cure as one of its side effects. The Pradaxa lawsuit brings counts of the following:

* Strict liability
* Negligence
* Breach of implied and express warranties
* Concealment with intent to deceive or mislead
* Loss of consortium

History of Pradaxa and Its Side Effects

Pradaxa is a blood-thinner designed to prevent blood clots in atrial fibrillation patients. The drug was approved on October 9, 2012 by the FDA and was the first anticoagulant approved for the treatment of non-valvular atrial fibrillation in the United States since warfarin was approved 50 years ago for the same treatment.

Pradaxa received praise because it was more user-friendly and did not require a special diet and constant monitoring as warfarin does. While patients of either drug run the risk of uncontrolled bleeding, warfarin patients can simply take Vitamin K to counteract the effects of the drug. However, Pradaxa users have no known means to counter potentially deadly Pradaxa bleeding side effects.

The 8 months in between October 2010 through June 2011 saw nearly 1,800 serious adverse event reports about Pradaxa internal bleeding side effects as received by the FDA. By the end of 2011, the following adverse Pradaxa side effects had been recorded:

* More than 500 deaths had been attributed to Pradaxa
* 900 Pradaxa gastrointestinal hemorrhages
* 300 Pradaxa rectal hemorrhages
* 200 Pradaxa cerebrovascular accidents

The FDA announced that it would conduct a Drug Safety Review of Pradaxa, investigating post-marketing reports of complications resulting from use of the drug. The announcement was made on December 7, 2011.

Current Pradaxa Internal Bleeding Lawsuit Status

Patients have filed many Pradaxa bleeding lawsuits over the serious adverse Pradaxa side effects they suffered, which include 21 federal Pradaxa lawsuits. Boehringer Ingelheim indicated its support of the creation of a Pradaxa lawsuit MDL by filing a document with the U.S. Judicial Panel on Multidistrict Litigation in June. As a result, a Pradaxa lawsuit MDL has been established at an Illinois central court.

The Pradaxa lawsuit MDL was created to handle the growing number of Pradaxa bleeding lawsuits in a time-efficient manner. The honorable Judge David Herndon will be handling the Pradaxa lawsuit MDL proceedings.

Pradaxa Side Effects

Common Pradaxa side effects include the following:

* Internal bleeding
* Kidney bleeding
* Gastrointestinal bleeding
* Heart attack
* Brain hemorrhage
* Death

If you, or someone you love, have experienced Pradaxa internal bleeding, kidney bleeding, gastrointestinal bleeding, heart attack, brain hemorrhage, or even death as a result of taking Pradaxa, it is very important that you get in touch with a Pradaxa lawsuit attorney right away. Please visit the Pradaxa Internal Bleeding Class Action Lawsuit Investigation page to receive your free consultation.